66 related articles for article (PubMed ID: 27943540)
41. Virulence Profiles of Vibrio vulnificus in German Coastal Waters, a Comparison of North Sea and Baltic Sea Isolates.
Bier N; Jäckel C; Dieckmann R; Brennholt N; Böer SI; Strauch E
Int J Environ Res Public Health; 2015 Dec; 12(12):15943-59. PubMed ID: 26694432
[TBL] [Abstract][Full Text] [Related]
42. The effect of T1 antigen on the virulence of salmonella strains for mice.
Valtonen VV; Sarvas M; Mäkelä PH
J Gen Microbiol; 1971 Nov; 69(1):99-106. PubMed ID: 4948191
[No Abstract] [Full Text] [Related]
43. The virulence factor ychO has a pleiotropic action in an Avian Pathogenic Escherichia coli (APEC) strain.
Pilatti L; Boldrin de Paiva J; Rojas TC; Leite JL; Conceição RA; Nakazato G; Dias da Silveira W
BMC Microbiol; 2016 Mar; 16():35. PubMed ID: 26965678
[TBL] [Abstract][Full Text] [Related]
44. New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia.
Jabbari J; Jabbari R; Nielsen MW; Holst AG; Nielsen JB; Haunsø S; Tfelt-Hansen J; Svendsen JH; Olesen MS
Circ Cardiovasc Genet; 2013 Oct; 6(5):481-9. PubMed ID: 24025405
[TBL] [Abstract][Full Text] [Related]
45. Western Database of Lipid Variants (WDLV): a catalogue of genetic variants in monogenic dyslipidemias.
Fu J; Kwok S; Sinai L; Abdel-Razek O; Babula J; Chen D; Farago E; Fernandopulle N; Leith S; Loyzer M; Lu C; Malkani N; Morris N; Schmidt M; Stringer R; Whitehead H; Ban MR; Dubé JB; McIntyre A; Johansen CT; Cao H; Wang J; Hegele RA
Can J Cardiol; 2013 Aug; 29(8):934-9. PubMed ID: 23623477
[TBL] [Abstract][Full Text] [Related]
46. Mutation clusters offer insight into predicting pathogenicity.
Greenblatt MS
Hum Mutat; 2010 Mar; 31(3):v. PubMed ID: 20162720
[No Abstract] [Full Text] [Related]
47. Evaluating LRRK2 genetic variants with unclear pathogenicity.
Refai FS; Ng SH; Tan EK
Biomed Res Int; 2015; 2015():678701. PubMed ID: 25821816
[TBL] [Abstract][Full Text] [Related]
48. Using reference databases of genetic variation to evaluate the potential pathogenicity of candidate disease variants.
Kenna KP; McLaughlin RL; Hardiman O; Bradley DG
Hum Mutat; 2013 Jun; 34(6):836-41. PubMed ID: 23447461
[TBL] [Abstract][Full Text] [Related]
49. [Experimental evaluation of the pathogenicity of Lassa virus variants].
Vladyko AS; Surikova LE; Vovk TA; Cherednichenko IA; Torop AV
Vopr Virusol; 1985; 30(4):454-7. PubMed ID: 4060702
[TBL] [Abstract][Full Text] [Related]
50. Development of pathogenicity predictors specific for variants that do not comply with clinical guidelines for the use of computational evidence.
de la Campa EÁ; Padilla N; de la Cruz X
BMC Genomics; 2017 Aug; 18(Suppl 5):569. PubMed ID: 28812538
[TBL] [Abstract][Full Text] [Related]
51. Are Functional Assays for Pathogenicity Assessment of Genetic Variants Overrated?
Sobrido MJ
Hum Mutat; 2017 Jan; 38(1):5. PubMed ID: 27943540
[No Abstract] [Full Text] [Related]
52. [Evaluation of variants of unknown significance in the BRCA2 gene].
Heczková M; Macháčková E; Jirsa M; Spičák J; Foretová L; Hucl T
Klin Onkol; 2012; 25 Suppl():S87-95. PubMed ID: 22920214
[TBL] [Abstract][Full Text] [Related]
53. Understanding the Pathogenicity of Noncoding Mismatch Repair Gene Promoter Variants in Lynch Syndrome.
Liu Q; Thompson BA; Ward RL; Hesson LB; Sloane MA
Hum Mutat; 2016 May; 37(5):417-26. PubMed ID: 26888055
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
